Olympus Corp
TSE:7733
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 021.5
2 850
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Olympus Corp
Current Assets | 657.1B |
Cash & Short-Term Investments | 274.9B |
Receivables | 169.1B |
Other Current Assets | 213.1B |
Non-Current Assets | 709.6B |
Long-Term Investments | 39.7B |
PP&E | 249.5B |
Intangibles | 260.7B |
Other Non-Current Assets | 159.7B |
Current Liabilities | 419.6B |
Accounts Payable | 53.7B |
Other Current Liabilities | 365.9B |
Non-Current Liabilities | 244B |
Long-Term Debt | 130.5B |
Other Non-Current Liabilities | 113.4B |
Balance Sheet
Olympus Corp
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
209 875
|
166 554
|
199 465
|
191 239
|
114 426
|
162 494
|
217 478
|
302 572
|
169 329
|
340 933
|
|
Cash Equivalents |
209 875
|
166 554
|
199 465
|
191 239
|
114 426
|
162 494
|
217 478
|
302 572
|
169 329
|
340 933
|
|
Short-Term Investments |
0
|
0
|
1 618
|
7 442
|
2 155
|
3 424
|
10 268
|
10 269
|
11 360
|
9 862
|
|
Total Receivables |
175 541
|
167 641
|
162 615
|
161 466
|
163 252
|
146 583
|
168 345
|
182 146
|
190 632
|
234 285
|
|
Accounts Receivables |
143 858
|
134 076
|
157 469
|
157 339
|
155 321
|
143 062
|
157 920
|
178 428
|
174 672
|
197 599
|
|
Other Receivables |
31 683
|
33 565
|
5 146
|
4 127
|
7 931
|
3 521
|
10 425
|
3 718
|
15 960
|
36 686
|
|
Inventory |
107 387
|
111 558
|
125 319
|
139 309
|
153 623
|
167 596
|
158 895
|
167 368
|
162 994
|
190 030
|
|
Other Current Assets |
84 725
|
74 939
|
16 730
|
14 835
|
22 576
|
26 610
|
25 087
|
32 250
|
192 042
|
25 230
|
|
Total Current Assets |
577 528
|
520 692
|
505 747
|
514 291
|
456 032
|
506 707
|
580 073
|
694 605
|
726 357
|
800 340
|
|
PP&E Net |
150 145
|
166 064
|
159 735
|
168 243
|
176 908
|
202 134
|
239 166
|
247 112
|
238 731
|
259 968
|
|
PP&E Gross |
150 145
|
166 064
|
159 735
|
168 243
|
176 908
|
202 134
|
239 166
|
247 112
|
238 731
|
259 968
|
|
Accumulated Depreciation |
274 809
|
281 999
|
301 897
|
314 297
|
328 359
|
346 443
|
369 391
|
417 964
|
404 233
|
441 956
|
|
Intangible Assets |
66 622
|
53 607
|
75 858
|
73 371
|
69 269
|
74 792
|
104 810
|
120 361
|
116 757
|
91 961
|
|
Goodwill |
114 025
|
97 190
|
95 568
|
97 208
|
101 188
|
98 328
|
127 384
|
164 498
|
181 324
|
180 331
|
|
Note Receivable |
16
|
0
|
18 303
|
17 971
|
14 618
|
19 685
|
24 577
|
27 857
|
36 980
|
55 764
|
|
Long-Term Investments |
72 263
|
71 141
|
37 946
|
39 727
|
35 248
|
29 533
|
26 478
|
17 666
|
22 486
|
34 625
|
|
Other Long-Term Assets |
100 952
|
91 920
|
66 875
|
67 852
|
78 767
|
84 484
|
80 965
|
85 900
|
186 066
|
111 227
|
|
Other Assets |
114 025
|
97 190
|
95 568
|
97 208
|
101 188
|
98 328
|
127 384
|
164 498
|
181 324
|
180 331
|
|
Total Assets |
1 081 551
N/A
|
1 000 614
-7%
|
960 032
-4%
|
978 663
+2%
|
932 030
-5%
|
1 015 663
+9%
|
1 183 453
+17%
|
1 357 999
+15%
|
1 508 701
+11%
|
1 534 216
+2%
|
|
Liabilities | |||||||||||
Accounts Payable |
39 155
|
40 597
|
70 834
|
57 559
|
61 724
|
59 557
|
69 870
|
60 547
|
62 919
|
61 855
|
|
Accrued Liabilities |
83 391
|
90 438
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Short-Term Debt |
29 118
|
6 656
|
2 409
|
0
|
629
|
70 135
|
5 458
|
67
|
3
|
0
|
|
Current Portion of Long-Term Debt |
72 017
|
53 253
|
69 672
|
91 992
|
62 397
|
10 883
|
26 071
|
52 214
|
49 967
|
69 988
|
|
Other Current Liabilities |
151 112
|
75 681
|
143 535
|
156 369
|
162 761
|
193 195
|
226 992
|
263 423
|
349 003
|
299 852
|
|
Total Current Liabilities |
374 793
|
266 625
|
286 450
|
305 920
|
287 511
|
333 770
|
328 391
|
376 251
|
461 892
|
431 695
|
|
Long-Term Debt |
254 251
|
271 703
|
223 326
|
164 489
|
127 344
|
199 897
|
323 735
|
333 846
|
290 087
|
229 628
|
|
Deferred Income Tax |
39 160
|
28 386
|
9 565
|
10 004
|
12 101
|
13 147
|
13 103
|
13 087
|
12 298
|
11 989
|
|
Minority Interest |
1 532
|
1 496
|
1 477
|
1 466
|
1 194
|
1 211
|
1 154
|
1 194
|
1 149
|
0
|
|
Other Liabilities |
56 093
|
49 617
|
44 463
|
53 991
|
62 687
|
96 891
|
122 744
|
123 453
|
103 190
|
103 718
|
|
Total Liabilities |
725 829
N/A
|
617 827
-15%
|
565 281
-9%
|
535 870
-5%
|
490 837
-8%
|
644 916
+31%
|
789 127
+22%
|
847 831
+7%
|
868 616
+2%
|
777 030
-11%
|
|
Equity | |||||||||||
Common Stock |
124 520
|
124 520
|
124 520
|
124 560
|
124 606
|
124 643
|
124 643
|
124 643
|
124 643
|
124 643
|
|
Retained Earnings |
114 077
|
173 417
|
185 226
|
237 316
|
238 275
|
275 833
|
278 243
|
305 057
|
371 064
|
493 401
|
|
Additional Paid In Capital |
90 940
|
90 940
|
91 779
|
91 502
|
91 310
|
91 157
|
90 835
|
91 239
|
92 150
|
92 032
|
|
Unrealized Security Profit/Loss |
12 019
|
3 725
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Treasury Stock |
1 111
|
1 122
|
1 122
|
4 775
|
4 764
|
98 135
|
98 048
|
45 589
|
28 086
|
102 017
|
|
Other Equity |
15 277
|
8 693
|
5 652
|
5 810
|
8 234
|
22 751
|
1 347
|
34 818
|
80 314
|
149 127
|
|
Total Equity |
355 722
N/A
|
382 787
+8%
|
394 751
+3%
|
442 793
+12%
|
441 193
0%
|
370 747
-16%
|
394 326
+6%
|
510 168
+29%
|
640 085
+25%
|
757 186
+18%
|
|
Total Liabilities & Equity |
1 081 551
N/A
|
1 000 614
-7%
|
960 032
-4%
|
978 663
+2%
|
932 030
-5%
|
1 015 663
+9%
|
1 183 453
+17%
|
1 357 999
+15%
|
1 508 701
+11%
|
1 534 216
+2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
1 369
|
1 369
|
1 369
|
1 366
|
1 366
|
1 286
|
1 286
|
1 273
|
1 254
|
1 166
|